Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein

Pharmacological Research - Tập 175 - Trang 105975 - 2022
Gamal Eldein Fathy Abd-ellatef1,2, Elena Gazzano1, Ahmed H. El-Desoky3, Ahmed R. Hamed4, Joanna Kopecka1, Dimas Carolina Belisario1, Costanzo Costamagna1, Mohamed Assem S. Marie5, Sohair R. Fahmy5, Abdel-Hamid Z. Abdel-Hamid2, Chiara Riganti1
1Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy
2Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., 12622 Dokki, Giza, Egypt
3Pharmacognosy Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., 12622 Dokki, Giza, Egypt
4Chemistry of Medicinal Plants Department & Biology Unit of Central Laboratory, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., 12622 Dokki, Giza, Egypt
5Zoology Department, Faculty of Science, Cairo University, Gamaa Street, Giza, Egypt

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Pharmacological Research

Tập 175

105975

Thông tin tác giả